Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1982 4
1983 18
1984 88
1985 96
1986 115
1987 111
1988 113
1989 125
1990 155
1991 143
1992 166
1993 161
1994 189
1995 178
1996 189
1997 189
1998 184
1999 203
2000 214
2001 193
2002 235
2003 267
2004 280
2005 283
2006 297
2007 305
2008 347
2009 357
2010 427
2011 434
2012 433
2013 434
2014 467
2015 431
2016 395
2017 360
2018 410
2019 209
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

8,344 results
Results by year
Filters applied: . Clear all
Page 1
Chemotherapy-induced peripheral neuropathy: Current status and progress.
Brewer JR, et al. Gynecol Oncol 2016 - Review. PMID 26556766 Free PMC article.
As there are increasing numbers of cancer survivors, more attention is being paid to the long term unwanted effects patients may experience as a result of their treatment and the impact these side effects can have on their quality of life. Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common long-term toxicities from chemotherapy. In this review we will briefly review the clinical presentation, evaluation and management of chemotherapy-induced peripheral neuropathy, with a focus on CIPN related to platinum and taxane agents. ...
As there are increasing numbers of cancer survivors, more attention is being paid to the long term unwanted effects patients may expe …
An overview of chemotherapy-related cognitive dysfunction, or 'chemobrain'.
Moore HC. Oncology (Williston Park) 2014 - Review. PMID 25224480 Free article.
These effects appear to be most pronounced in the short-term, with improvement over time expected for most patients. Pharmacologic treatments do not have proven value in the management of chemotherapy-related cognitive dysfunction, but patients may benefit from cognitive rehabilitation. Clinical guidelines are needed for assessment and management of chemotherapy-related cognitive dysfunction....
These effects appear to be most pronounced in the short-term, with improvement over time expected for most patients. Pharmacologic tr …
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
Hurria A, et al. J Clin Oncol 2011 - Clinical Trial. PMID 21810685 Free PMC article.
PURPOSE: Older adults are vulnerable to chemotherapy toxicity; however, there are limited data to identify those at risk. The goals of this study are to identify risk factors for chemotherapy toxicity in older adults and develop a risk stratification schema for chemotherapy toxicity. ...Patients were followed through the chemotherapy course to capture grade 3 (severe), grade 4 (life-threatening or disabling), and grade 5 (death) as defined by the National Cancer Institute Common Terminology Criteria for Adverse Events. ...
PURPOSE: Older adults are vulnerable to chemotherapy toxicity; however, there are limited data to identify those at risk. The goals o …
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
Molassiotis A, et al. BMC Cancer 2019 - Clinical Trial. PMID 30736741 Free PMC article.
BACKGROUND: There are inconsistencies in the literature regarding the prevalence and assessment of chemotherapy-induced peripheral neuropathy (CIPN). This study explored CIPN natural history and its characteristics in patients receiving taxane- and platinum-based chemotherapy. ...
BACKGROUND: There are inconsistencies in the literature regarding the prevalence and assessment of chemotherapy-induced peripheral ne …
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice.
Weycker D, et al. BMC Cancer 2019. PMID 30764783 Free PMC article.
BACKGROUND: Chemotherapy-induced thrombocytopenia (CIT) is a potentially serious complication that can lead to chemotherapy dose delays, dose reductions, or discontinuation, and increases the risk of serious bleeding events. ...Study population comprised adults who received selected myelosuppressive chemotherapy regimens for solid tumors or non-Hodgkin's lymphoma. ...
BACKGROUND: Chemotherapy-induced thrombocytopenia (CIT) is a potentially serious complication that can lead to chemotherapy do …
[Cardiotoxicity of chemotherapies].
Castel M, et al. Presse Med 2013 - Review. PMID 22727981 French.
Many cardiovascular adverse effects appear with cancer therapy and suspend treatment purchase, or leading to an alteration of quality of life, and increasing mortality risks. ...Cardiovascular adverse effects are associated with the use of targeted therapies such as tyrosine kinase inhibitors: trastuzumab, bevacizumab. ...
Many cardiovascular adverse effects appear with cancer therapy and suspend treatment purchase, or leading to an alteration of …
Chemotherapy Toxicity Risk Score for Treatment Decisions in Older Adults with Advanced Solid Tumors.
Nishijima TF, et al. Oncologist 2018. PMID 29371477 Free PMC article.
MATERIALS AND METHODS: This was a prospective observational study of patients aged ≥65 years receiving first-line chemotherapy for advanced cancer for which combination chemotherapy is the standard of care. ...IMPLICATIONS FOR PRACTICE: The potential utility of the chemotherapy toxicity risk score (CTRS) in old adults with advanced solid tumors receiving first-line chemotherapy was assessed. ...
MATERIALS AND METHODS: This was a prospective observational study of patients aged ≥65 years receiving first-line chemotherapy for ad …
8,344 results
Jump to page
Feedback